Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,034.23 10.14 (0.99%) as of 4:30 Fri 7/5


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 108.27(B)
Last Volume: 418,302 Avg Vol: 758,271
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,995 237,237 312,646 469,880
Total Sell Value $189,656,342 $231,855,596 $295,997,978 $406,115,303
Total People Sold 7 13 16 18
Total Sell Transactions 18 40 67 129
End Date 2024-04-07 2024-01-05 2023-07-07 2022-07-07

   
Records found: 2433
  Page 74 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-10-04 4 OE $9.49 $151,712 D/D 13,749 91,483     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-21 4 AS $67.00 $281,400 D/D (4,200) 77,734     -
   Brown Michael S Director   –       •      –    2011-09-21 4 AS $78.00 $390,000 D/D (5,000) 14,662     -
   Brown Michael S Director   –       •      –    2011-09-21 4 OE $9.17 $45,850 D/D 5,000 19,662     -
   Goldstein Joseph L Director   –       •      –    2011-09-20 4 A $0.00 $0 D/D 10,000 10,000     -
   Ryan Arthur F Director   –       •      –    2011-09-14 4 D $64.85 $2,084,603 D/D (32,145) 92,855     -
   Ryan Arthur F Director   –       •      –    2011-09-14 4 OE $9.17 $2,085,050 D/D 115,000 94,736     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-09 4 AS $67.19 $511,409 D/D (7,542) 81,934     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-08 4 D $72.60 $1,035,131 D/D (14,258) 89,476     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-08 4 OE $11.64 $302,640 D/D 26,000 103,734     -
   Brown Michael S Director   –       •      –    2011-09-08 4 AS $74.00 $370,000 D/D (5,000) 14,662     -
   Brown Michael S Director   –       •      –    2011-09-08 4 OE $9.17 $45,850 D/D 5,000 19,662     -
   Roberts William VP Regulatory Development and   •       –      –    2011-09-07 4 AS $67.48 $453,324 D/D (6,503) 66,956     -
   Brown Michael S Director   –       •      –    2011-09-07 4 AS $69.00 $345,000 D/D (5,000) 14,662     -
   Brown Michael S Director   –       •      –    2011-09-07 4 OE $9.17 $45,850 D/D 5,000 19,662     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-07 4 AS $67.50 $943,570 D/D (13,531) 77,734     -
   Stahl Neil SVP Research and Development S   •       –      –    2011-09-07 4 AS $67.47 $2,354,375 D/D (33,760) 50,350     -
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2011-09-07 4 AS $67.39 $235,256 D/D (3,377) 10,000     -
   Roberts William VP Regulatory Development and   •       –      –    2011-09-06 4 AS $62.76 $1,092,649 D/D (16,463) 73,459     -
   Roberts William VP Regulatory Development and   •       –      –    2011-09-06 4 OE $11.64 $349,200 D/D 30,000 75,144     -
   Roberts William VP Regulatory Development and   •       –      –    2011-09-06 4 D $65.76 $462,556 D/D (7,034) 73,459     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-06 4 D $65.76 $1,272,324 D/D (19,348) 91,265     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2011-09-06 4 OE $11.64 $507,827 D/D 32,879 101,240     -
   Stahl Neil SVP Research and Development S   •       –      –    2011-09-06 4 D $65.76 $3,226,054 D/D (49,058) 84,110     -
   Stahl Neil SVP Research and Development S   •       –      –    2011-09-06 4 OE $11.64 $964,002 D/D 82,818 133,168     -
  2433 Records found
  Previous  70  71  72  73  74  75  76  77  78  79  Next   
  Page 74 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us